Amneal Pharmaceuticals is trading at $17.43, up +4.65%, amid stronger market sentiment.
- No major company-specific announcement dated September 16, 2026 was identified; recent official releases concern earlier FDA approvals and second-quarter results.
- The Nasdaq is up 0.91%, while investors favor growth stocks ahead of the Federal Reserve decision.
- Intraday volume and activity-level data were unavailable; the catalyst may remain macro-driven.